<?xml version="1.0" encoding="UTF-8"?>
<jcr:root xmlns:sling="http://sling.apache.org/jcr/sling/1.0" xmlns:cq="http://www.day.com/jcr/cq/1.0" xmlns:jcr="http://www.jcp.org/jcr/1.0" xmlns:mix="http://www.jcp.org/jcr/mix/1.0" xmlns:nt="http://www.jcp.org/jcr/nt/1.0"
    jcr:primaryType="cq:Page">
    <jcr:content
        cq:lastModified="{Date}2014-04-24T13:26:19.066-04:00"
        cq:lastModifiedBy="churydx"
        cq:lastReplicated="{Date}2014-04-03T01:21:13.265-04:00"
        cq:lastReplicatedBy="admin"
        cq:lastReplicationAction="Activate"
        cq:template="/apps/aah/paccalVet/templates/vetTemplate"
        jcr:isCheckedOut="{Boolean}true"
        jcr:mixinTypes="[mix:versionable]"
        jcr:primaryType="cq:PageContent"
        jcr:title="Cremophor Free"
        jcr:uuid="5d601cee-3237-4604-8ce0-d8aff76089df"
        sling:resourceType="aah/paccalVet/components/pages/vetTemplate"
        commodityNumber="AAHW-2105 Feb 2014">
        <center
            jcr:primaryType="nt:unstructured"
            sling:resourceType="foundation/components/parsys">
            <headline
                jcr:created="{Date}2013-11-25T22:23:50.831-05:00"
                jcr:createdBy="kiransr"
                jcr:lastModified="{Date}2014-03-26T21:06:31.923-04:00"
                jcr:lastModifiedBy="churydx"
                jcr:primaryType="nt:unstructured"
                sling:resourceType="aah/paccalVet/components/base/headLine"
                heading="Paccal Vet®-CA1: the cancer treatment you can feel comfortable prescribing to your canine patients."/>
            <textpanel
                jcr:created="{Date}2013-11-25T22:24:05.928-05:00"
                jcr:createdBy="kiransr"
                jcr:lastModified="{Date}2014-04-24T13:19:30.555-04:00"
                jcr:lastModifiedBy="churydx"
                jcr:primaryType="nt:unstructured"
                sling:resourceType="aah/paccalVet/components/base/textpanel"
                sectioncopy="&lt;p>In a large-scale study, 1% (2/168) of dogs treated with Paccal Vet-CA1 experienced allergic or anaphylactic hypersensitivity reactions, so there’s no need for premedication with antihistamines or corticosteroids to reduce hypersensitivity reactions to Cremophor&lt;sup>1&lt;/sup>.&lt;/p>&#xa;&lt;p>Paccal Vet-CA1 has demonstrated all target animal safety (TAS) requirements and has received full FDA safety approval.&lt;/p>&#xa;&lt;p>Paccal Vet-CA1 is manufactured in a FDA-registered facility in accordance with good manufacturing practices.&lt;/p>&#xa;&lt;p>&amp;nbsp;&lt;/p>&#xa;&lt;p>&lt;b>Please see full &lt;u>&lt;a href=&quot;/content/dam/aah/paccalvet/docs/PaccalVet-CA1%20PAC-2063_PI.pdf&quot; target=&quot;_blank&quot;>Prescribing Information&lt;/a>&lt;/u>&amp;nbsp;for Warnings, Precautions, Contraindication, and a complete list of Adverse Reactions.&lt;/b>&lt;/p>&#xa;"/>
        </center>
        <bottom
            jcr:primaryType="nt:unstructured"
            sling:resourceType="foundation/components/parsys">
            <textpanel
                jcr:created="{Date}2013-12-04T16:46:58.941-05:00"
                jcr:createdBy="kiransr"
                jcr:lastModified="{Date}2014-04-24T13:26:19.063-04:00"
                jcr:lastModifiedBy="churydx"
                jcr:primaryType="nt:unstructured"
                sling:resourceType="aah/paccalVet/components/base/textpanel"
                sectioncopy="&lt;p>&lt;b>References&lt;/b>&lt;/p>&#xa;&lt;p>&lt;b>1.&lt;/b> Poirier VJ, Hershey AE, Burgess KE, Phillips B, Turek MM, Forrest LJ, et al. Efficacy and toxicity of paclitaxel (taxol) for the treatment of canine malignant tumors.&amp;nbsp;&lt;em>J Vet Intern Med&lt;/em>. 2004;18:219-222.&lt;/p>&#xa;"/>
        </bottom>
        <image
            jcr:lastModified="{Date}2014-03-26T21:10:32.461-04:00"
            jcr:lastModifiedBy="churydx"
            jcr:primaryType="nt:unstructured"
            imageRotate="0"/>
    </jcr:content>
</jcr:root>
